FDA-Drug2026-04-01Class IIPROCESSING DEFECT
Meclizine Hydrochloride 12.5 mg tablets recalled for failed specifications
What this means
American Health Packaging is recalling specific batches of Meclizine Hydrochloride 12.5 mg tablets because they failed to meet required tablet specifications. The affected product is Lot #1024852 with an expiration date of 9/30/2026. No injuries have been reported.
- Check if you have Meclizine Hydrochloride tablets with Lot #1024852 and expiration 9/30/2026
- Do not use the recalled tablets
- Contact your pharmacy or prescriber for a replacement or alternative medication
- Return the recalled medication to your pharmacy
The agency's original wording
Hazard
Failed tablet specifications.
Intended for
Adults
Illnesses reported
None reported
Sold states
U.S. Nationwide
Affected count
697 cartons
Manufactured in
2550 John Glenn Ave Ste A, Columbus, OH, United States
Products
Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0418-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.